Blue Bird, First Solar rise; Harrow Health, Telesis Bio fall

NEW YORK — Stocks that traded heavily or had substantial price changes Friday:

Blue Bird Corp., up $7.01 to $26.33.

The school bus maker beat Wall Street’s fiscal second-quarter earnings and revenue forecasts.

Telesis Bio, Inc., down 35 cents to $2.53.

The synthetic biology company reported disappointing first-quarter revenue.

Harrow Health, Inc., down $5.03 to $ 22.04.

The make of ophthalmological pharmaceuticals reported a bigger first-quarter loss than analysts expected.

News Corp., up $1.46 to $18.29.

The publisher of The Wall Street Journal beat analysts’ fiscal third-quarter profit and revenue forecasts.

Agile Therapeutics Inc., down 68 cents to $5.

The developer of prescription contraceptive products for women reported disappointing first-quarter earnings.

Spectrum Brands Holdings Inc., down 64 cents to $70.70.

The maker of Nature’s Miracle and other household products reported weak second-quarter revenue.

First Solar Inc., up $48.50 to $231.69.

The solar technology company is buying Sweden’s Evolar.

IonQ Inc., down 67 cents to $6.35.

The quantum computing technology company reported weak first-quarter earnings.